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P U B L I S H E D B Y E L S E V I E R I N C .LETTERS TO THE EDITORPrevalence and Prognostic Signiﬁcance of
Lipomatous Metaplasia in Patients With Prior
Myocardial InfarctionIt has been noted recently, initially in pathological
specimens, that infarcted myocardium can be inﬁl-
trated by adipose cells, known as lipomatous meta-
plasia (LM). It has been suggested that the presence of
myocardial fat may interfere with the conduction
system of the heart, perhaps providing a substrate for
sudden cardiac death (1).
Recent studies have aimed to noninvasively
characterize the incidence of LM using both com-
puted tomography and cardiac magnetic resonance
(CMR), although the studies have been limited
by small size or retrospective nature (2,3). We
aimed to prospectively evaluate the prognostic
signiﬁcance of LM in an unselected cohort of
patients.
We prospectively evaluated 316 consecutive
patients who had a remote history of type 1 myocar-
dial infarction (MI) (>6 months) referred by their
physician for CMR at our institution. All patients were
evaluated using a 1.5-T scanner. Cine images were
obtained for assessment of mass and function using
a steady-state free precession sequence. Following
this, T2-weighted imaging was conducted in 3
matched short-axis slices using a short TI inversion
recovery (STIR) sequence. Then an identical
sequence was performed without a third inversion
pulse (T2-STIR) to remove the inherent fat sup-
pression. Finally, late gadolinium enhancement im-
aging was performed. An example is shown in
Figures 1A to 1E. All patients were followed for a
combined primary outcome of all-cause mortality,
sustained ventricular arrhythmia, and heart failure
hospitalization.
The average age of the study population was
58.6  10.9 years. Most patients were male (75.3%).
Median time from MI to CMR was 4.0 years. Using
our diagnostic criteria, 77 patients (24.4%) had
evidence of LM. LMþ patients had older infarcts
(median infarct age 8.00 years; interquartile range
[IQR]: 2.00 to 14.00 years vs. 3.00 years; IQR: 1.00 to
8.50; p < 0.001) that were more extensive (infarctsize 31.56  12.08% vs. 20.45  14.91%; p < 0.001).
There was no signiﬁcant difference in the use of
medications between the 2 groups. LM was not
associated with typical clinical risk factors or prior
percutaneous coronary intervention or coronary
artery bypass graft.
LMþ patients had lower left ventricular ejection
fraction (LVEF) (33.1  13.1% vs. 42.6  15.0%;
p < 0.001) and higher LV end-diastolic volume
(136.0  50.2 ml/m2 vs. 108.1  38.7 ml/m2; p < 0.001).
The primary outcome occurred in 46 patients, 23
LMþ (29.9%) and 23 LM (9.6%). In a multivariable
model containing the strongest other predictors
(atrial ﬁbrillation, LVEF, diabetes, and multivessel
disease), LM remained a signiﬁcant predictor of the
primary outcome (hazard ratio: 2.67; 95% conﬁdence
interval: 1.44 to 4.96; p ¼ 0.002) (Figure 1F).
We found that the presence of LM was associated
with more adverse remodeling and larger infarcts.
Our ﬁndings are in keeping with the original land-
mark study of Baroldi et al. (1).
Infarct age was the only clinical feature found to
be associated with LM, suggesting that its devel-
opment is progressive (1,3). Similar to previously
published studies, we did not ﬁnd any other clinical
associations with LM (2,3). The pathogenesis of LM
within myocardial infarcts is not clearly understood
as of yet; however, it is known that areas of MI scar
display abnormal metabolism with reduced uptake
of fatty acids, leading to the replacement of
collagen with adipocytes (1). It is postulated that
newer medical and reperfusion therapies might
reduce the development of LM. The prevalence
of LM in our study was similar to that in earlier
histopathologic studies despite these therapeutic
advances.
The presence of LM was a stronger predictor than
infarct size alone and remained signiﬁcant when
added to LV volumes or LVEF. A recent study in an
ovine model by Pouliopoulos et al. (4) found that the
presence of LM in sheep with experimentally induced
myocardial infarcts was associated with more in-
ducible ventricular tachycardia. The presence of
myocardial fat has also been associated with induc-
ible ventricular tachycardia in humans in the right
ventricle. It may be that adipose tissue predisposes to
re-entrant tachycardias and impairs myocardial con-
duction, leading to increased risk of ventricular
arrhythmias and death (4).
FIGURE 1 A Patient With LM Following a Prior Anterior Myocardial Infarction
Computed tomography (CT) coronary angiography revealed an area of hypointense signal
in the anterior wall typical of lipomatous metaplasia (LM) (A). Steady-state free precession
cine imaging showed a chemical shift artifact within the anterior wall (B). T2–short TI
inversion recovery (STIR)þ imaging revealed a hypointense area similar to that seen by CT
(C) that was not apparent on T2-STIR imaging (D). Late gadolinium enhancement im-
aging conﬁrmed an anterior myocardial infarct with no evidence of microvascular
obstruction (E). LM was associated with adverse outcome (F).
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tachycardia. Circulation 2013;128:2296–308.Can Computational Simulation Quantitatively
Determine Mitral Valve Abnormalities?Various pathologies of the mitral valve (MV) apparatus
include excessive annular dilation, chordal elonga-
tion, chordal rupture, and leaﬂet tissue enlargement,
which lead to mitral regurgitation (MR) (1). The rec-
ommended treatment for these MV pathologies
accompanied by severe MR is MV reconstruction,
which has been shown to improve event-free survival
(2). Echocardiography is the primary imaging modality
to provide MV pathological information and the
proper timing for consideration of MV repair (3).
In a recent issue, we demonstrated 4 cases of
computational evaluation of MV function (4). Here
we extend our patient-speciﬁc computational MV
evaluation studies to quantitatively determine the
biomechanical and physiological characteristics of
MV function involving severe annular dilation.
Five patients with normal MV and 5 patients
with severe annular dilation accompanied by MR
were recruited, and 3-dimensional (3D) trans-
esophageal echocardiography (TEE) was performed.
Patient-speciﬁc 3D TEE data were converted into
computational MV models followed by dynamic sim-
ulations to evaluate MV function (5). Stress and con-
tact pressure distributions across the mitral leaﬂets
were determined at peak systole. A ratio of the
coapted leaﬂet area to the entire posterior leaﬂet area
was calculated and compared between the normal
and pathological MV groups.
The normal MVs clearly showed 3D cyclic deforma-
tion of the saddle-shaped annular morphology
across the cardiac cycle. The pathological MVs dis-
playing severe MR revealed larger annular sizes and
less elliptical annular morphology compared with the
normal MVs. Representative stress distributions across
the mitral leaﬂets at peak systole are demonstrated in
Figures 1A and 1B. Symmetrical stress distribution pat-
terns were found over both anterior and posterior
leaﬂets in the normalMVs. In contrast, the pathological
MVs with severe annular dilation revealed markedly
asymmetrical stress patterns with high stress values
spread along the radial direction. The pathological
MVs demonstrated higher average maximum stress
values (1.3  0.2 MPa; p < 0.01) than the normal MVs
(0.8  0.2 MPa). These excessive stress concentrations
were found in regions involving incomplete leaﬂet
coaptation. From a biomechanical perspective, this
ﬁnding implies that severe annular dilation with nor-
mal left ventricular function generates high stresses
